AMPUTATION AND CISPLATIN FOR TREATMENT OF CANINE OSTEOSARCOMA

被引：145

作者：

STRAW, RC

WITHROW, SJ

RICHTER, SL

POWERS, BE

KLEIN, MK

POSTORINO, NC

LARUE, SM

OGILVIE, GK

VAIL, DM

MORRISON, WB

MCGEE, M

DICKINSON, K

机构：

[1] College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, Colorado

[2] School of Veterinary Medicine, Purdue University, West Lafayette, Indiana

来源：

JOURNAL OF VETERINARY INTERNAL MEDICINE | 1991年 / 5卷 / 04期

关键词：

D O I：

10.1111/j.1939-1676.1991.tb00950.x

中图分类号：

S85 [动物医学（兽医学）];

学科分类号：

0906 ;

摘要：

Seventy-one dogs with histologically confirmed appendicular osteosarcoma were evaluated. Seventeen dogs were treated with amputation and two dogs received postoperative doses of IV cisplatin given 21 days apart (group 1). Nineteen dogs were treated with IV cisplatin given 21 days apart (group 1). Nineteen dogs were treated with IV cisplatin 21 days before amputation, with a second dose given immediately after amputation (group 2). Thirty-five dogs were treated by amputation of the affected limb with no chemotherapy (group 3). The median disease-free interval for group 1 was 226 days, and 177 days for group 2. This was not significantly different. The median survival time was 262 days for group 1, 282 days for group 2 and 119 days for group 3. Group 1 and 2 dogs had survival times that were significantly longer than for dogs in group 3. Two IV courses of cisplatin given before or after amputation appears to improve the survival of dogs with osteosarcoma.

引用

页码：205 / 210

页数：6

共 34 条

[1] Lui SK, Dorfman HD, Hurvitz AI, Et al., Primary and secondary bone tumors in the dog, Journal of Small Animal Practice, 18, pp. 313-326, (1977)
[2] Probst CW, Ackerman N., Malignant neoplasia of the canine appendicular skeleton, Compend Contin Educ Pract Vet, 4, pp. 260-270, (1982)
[3] Brodey RS., The use of naturally occurring cancer in domestic animals for research into human cancer: General considerations and a review of canine skeletal osteosarcoma, Yale J Biol Med, 52, pp. 345-361, (1979)
[4] Shapiro W., Fossum TW, Kitchell BE, Et al., Use of cisplatin for the treatment of appendicular osteosarcoma in dogs, J Am Vet Med Assoc, 4, pp. 507-511, (1988)
[5] Mauldin GN, Matus RE, Withrow SJ, Et al., Canine osteosarcoma treatment by amputation versus amputation and adjuvant chemotherapy using doxorubicin and cisplatin, J Vet Int Med, 2, pp. 177-180, (1988)
[6] Brodey RS, Abt DA., Results of surgical treatment in 65 dogs with osteosarcoma, J Am Vet Med Assoc, 168, pp. 1032-1035, (1976)
[7] Madewell BR, Leighton RC, Theilen GH., Amputation and doxorubicin for treatment of canine and feline osteogenic sarcoma, Eur J Cancer, 4, pp. 287-293, (1978)
[8] Cotter SM, Parker LM., High dose methotrexate and leucovorin rescue in dogs with osteogenic sarcoma, Am J Vet Res, 39, pp. 1943-1945, (1978)
[9] Meyer JA, Deuland RT, MacEwen, Et al., Canine osteogenic sarcoma treated by amputation and MER: An adverse effect of splenectomy on survival, Cancer, 49, pp. 1613-1616, (1982)
[10] Hamilton HB, LaRue SM, Withrow SJ., Effect of RA233 on metastasis in dogs with osteosarcomas, Am J Vet Res, 48, pp. 1380-1382, (1987)

← 1 2 3 4 →